Business Description
Eagle Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US2697961082
Share Class Description:
FRA:1E6: Ordinary SharesDescription
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.39 | |||||
| 9-Day RSI | 13.43 | |||||
| 14-Day RSI | 19.86 | |||||
| 6-1 Month Momentum % | -23.18 | |||||
| 12-1 Month Momentum % | -72.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -3.83 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eagle Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 245.457 | ||
| EPS (TTM) (€) | 0.811 | ||
| Beta | 0 | ||
| Volatility % | 90.14 | ||
| 14-Day RSI | 19.86 | ||
| 14-Day ATR (€) | 0.130358 | ||
| 20-Day SMA (€) | 2.773 | ||
| 12-1 Month Momentum % | -72.07 | ||
| 52-Week Range (€) | 1.76 - 13.1 | ||
| Shares Outstanding (Mil) | 12.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eagle Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eagle Pharmaceuticals Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eagle Pharmaceuticals Inc Frequently Asked Questions
What is Eagle Pharmaceuticals Inc(FRA:1E6)'s stock price today?
The current price of FRA:1E6 is €1.76. The 52 week high of FRA:1E6 is €13.10 and 52 week low is €1.76.
When is next earnings date of Eagle Pharmaceuticals Inc(FRA:1E6)?
The next earnings date of Eagle Pharmaceuticals Inc(FRA:1E6) is 2024-11-06 Est..
Does Eagle Pharmaceuticals Inc(FRA:1E6) pay dividends? If so, how much?
Eagle Pharmaceuticals Inc(FRA:1E6) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers